443 related articles for article (PubMed ID: 17357613)
1. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
2. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
3. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
4. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Grasko JM; Herrmann RP; Vasikaran SD
J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
[No Abstract] [Full Text] [Related]
5. Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga D; Garatea-Crelgo J; Martino-Gorbea R; Etayo-Pérez A; Sebastián-López C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E76-9. PubMed ID: 16388300
[TBL] [Abstract][Full Text] [Related]
6. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Dimopoulos MA; Kastritis E; Anagnostopoulos A; Melakopoulos I; Gika D; Moulopoulos LA; Bamia C; Terpos E; Tsionos K; Bamias A
Haematologica; 2006 Jul; 91(7):968-71. PubMed ID: 16757414
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
10. A time for perspective on bisphosphonates.
Assael LA
J Oral Maxillofac Surg; 2006 Jun; 64(6):877-9. PubMed ID: 16713799
[No Abstract] [Full Text] [Related]
11. Bisphosphonates: a potential threat to your patients.
Dreiman BB
J Indiana Dent Assoc; 2005-2006 Winter; 84(4):4-9. PubMed ID: 16605211
[No Abstract] [Full Text] [Related]
12. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
Olson KB; Hellie CM; Pienta KJ
Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Jimenez-Soriano Y; Bagan JV
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
[No Abstract] [Full Text] [Related]
15. Osteonecrosis of the jaw and bisphosphonates.
Durie BG; Katz M; Crowley J
N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
[No Abstract] [Full Text] [Related]
16. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
[TBL] [Abstract][Full Text] [Related]
17. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
Montazeri AH; Erskine JG; McQuaker IG
Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
19. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
Smith A; Kressley A; Saif MW
JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
[No Abstract] [Full Text] [Related]
20. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
Junquera L; Gallego L
J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
